Dr. Fiore is a pharmaceutical/biotechnology executive and entrepreneur and is the Founder of Fiore Healthcare Advisors (FHA). He is a Co-Founder and is the CEO of Sollis Therapeutics as well as the Founder of the life science consultancies SSI Strategy (SSI). He currently serves as advisor to FHA and SSI.
Dr. Fiore is a recognized expert in clinical research and pharmacovigilance (PV) and has particular passion for designing approaches to ensure the safety of subjects exposed to marketed drugs and to products in clinical trials. He has overseen safety and clinical research for more than 10 therapy areas and has experience in the US, Europe, Asia Pacific, and Latin America.
Prior to founding FHA, Dr. Fiore was the Chief Medical Officer of The Medicines Company (MDCO) and had served in a variety of executive roles at MDCO earlier in his career. Dr. Fiore also founded SSI Strategy, a life sciences management consulting firm that combines business consulting discipline with pharmaceutical domain expertise. Prior to SSI, Dr. Fiore spent time in roles of increasing responsibility in companies such as Merck, Schering-Plough, and Abbott Laboratories.
Dr. Fiore was valedictorian at New York Medical College and completed training in Internal Medicine at Harvard Medical School's Brigham and Women’s Hospital and then underwent further clinical training in Pulmonary and Critical Care Medicine in the Harvard Pulmonary and Critical Care fellowship program. From Harvard he joined McKinsey & Company where he worked on projects in a variety of industries including pharmaceuticals.
Dr. Fiore was a member of the CIOMS IX working group on Risk Minimization and has served on several safety and business advisory committees, including in the role of Chairperson. He is a Scientific Advisory Board member for Adverse Events, Inc. as well as Editorial Advisory Board member of Clinical Leader, an online journal aimed at providing solutions for the Pharmaceutical Industry.